title: Isis and antisense face crucial test without Novartis.
authors.forename: A
authors.initials: A
authors.lastname: Dove
mesh_terms: D016375:Antisense Elements (Genetics) / Q000191:economics / Q000627:therapeutic use*; D001709:Biotechnology / Q000191:economics; D002140:California; D002986:Clinical Trials as Topic / Q000191:economics; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D008389:Marketing of Health Services
chemical_list: D016375:Antisense Elements (Genetics)